Trials / Conditions / Chronic Schizophrenia

Chronic Schizophrenia

16 registered clinical trials studyying Chronic Schizophrenia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Effect of tDCS on Inflammatory Biomarkers in Chronic Schizophrenia NCT06349369	All India Institute of Medical Sciences, Bhubaneswar	N/A
Unknown	Experience of Horticultural Group Therapy Among People With Chronic Schizophrenia NCT05948696	TsaoTun Psychiatric Center, Department of Health, Taiwan	—
Completed	Resourcefulness Group Intervention on Recovery and Quality of Life NCT06206798	National Taipei University of Nursing and Health Sciences	N/A
Completed	Study of Experience of High-frequency Repetitive Transcranial NCT05809882	Rongjun Hospital of Hebei Province Affiliated to North China University of Science and Technology	N/A
Completed	A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia NCT02624167	Newron Pharmaceuticals SPA	Phase 2
Completed	The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging Study NCT02421146	Northwell Health	N/A
Completed	Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients NCT02298985	Beersheva Mental Health Center	Phase 4
Completed	Cognitive Remediation and Sheltered Employment in Schizophrenia NCT01891929	Hôpital le Vinatier	N/A
Completed	Role of Nintendo Wii in Improving Negative Symptoms and Quality of Life in Chronic Schizophrenia NCT01761383	Queen's University	N/A
Completed	POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia NCT01450514	PharmaNeuroBoost N.V.	Phase 2
Completed	Integrated Psychological Therapy for Chronic Schizophrenia NCT03275909	University of the Basque Country (UPV/EHU)	N/A
Completed	Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia NCT00789698	Sumitomo Pharma America, Inc.	Phase 3
Unknown	Oxygen Therapy in Schizophrenia NCT00525863	Beersheva Mental Health Center	Phase 3
Unknown	Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia NCT00664274	Manhattan Psychiatric Center	N/A
Completed	An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizo NCT00161044	University of Maryland, Baltimore	N/A
Terminated	Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophre NCT00148616	M. Schaefer, MD	Phase 3